Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard P Baum

Showing results (11-20 of 198) with videos related to

Pageof 20
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2015
Third Theranostics World Congress on Gallium-68 and PRRT: AbstractsRichard P Baum, Richard L Wahl
PET Clinics|July 18, 2014
Patient selection for personalized peptide receptor radionuclide therapy using Ga-68 somatostatin receptor PET/CTHarshad R Kulkarni, Richard P Baum
European Journal of Nuclear Medicine and Molecular Imaging|January 5, 2022
The ICPO Foundation-on the way toward collaborative growth of theranosticsRichard P Baum, Josh Mailman, Odile Jaume
European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2025
Cost-utility analysis of <sup>177</sup>Lu-PSMA-617 radioligand therapy in second-line and third-line treatment for metastatic castration-resistant prostate cancer (mCRPC) in GermanyCarolin Brinkmann, Richard P Baum, Tom Stargardt
Clinical Nuclear Medicine|March 7, 2012
Intense 18F-fluoride accumulation in liver metastases from a neuroendocrine tumor after peptide receptor radionuclide therapyCyprian Swiętaszczyk, Vikas Prasad, Richard P Baum
Annals of Nuclear Medicine|November 8, 2022
Celebrating 80 years anniversary of radioiodine for use in thyroid cancer and perspectives for theranosticsBarbara Hertz, Tadashi Watabe, Richard P Baum
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 28, 2007
Changing role of somatostatin receptor targeted drugs in NET: Nuclear Medicine's viewVikas Prasad, S Fetscher, Richard P Baum
Theranostics|December 8, 2025
Intra-arterial peptide receptor radionuclide therapy (IA-PRRT) in patients with SSTR-expressing neuroendocrine neoplasms: short- and long-term safety and efficacy for up to 13 yearsJingjing Zhang, Birger Mensel, Richard P Baum
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
Purification and labeling strategies for (68)Ga from (68)Ge/ (68)Ga generator eluateDirk Mueller, Ingo Klette, Richard P Baum
Frontiers of Radiation Therapy and Oncology|December 4, 2009
FDG-PET/CT in lung cancer: an updateRichard P Baum, Cyprian Świętaszczyk, Vikas Prasad
Pageof 20

Showing results (11-20 of 198) with videos related to

Sort By:
Pageof 20
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2015
Third Theranostics World Congress on Gallium-68 and PRRT: AbstractsRichard P Baum, Richard L Wahl
PET Clinics|July 18, 2014
Patient selection for personalized peptide receptor radionuclide therapy using Ga-68 somatostatin receptor PET/CTHarshad R Kulkarni, Richard P Baum
European Journal of Nuclear Medicine and Molecular Imaging|January 5, 2022
The ICPO Foundation-on the way toward collaborative growth of theranosticsRichard P Baum, Josh Mailman, Odile Jaume
European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2025
Cost-utility analysis of <sup>177</sup>Lu-PSMA-617 radioligand therapy in second-line and third-line treatment for metastatic castration-resistant prostate cancer (mCRPC) in GermanyCarolin Brinkmann, Richard P Baum, Tom Stargardt
Clinical Nuclear Medicine|March 7, 2012
Intense 18F-fluoride accumulation in liver metastases from a neuroendocrine tumor after peptide receptor radionuclide therapyCyprian Swiętaszczyk, Vikas Prasad, Richard P Baum
Annals of Nuclear Medicine|November 8, 2022
Celebrating 80 years anniversary of radioiodine for use in thyroid cancer and perspectives for theranosticsBarbara Hertz, Tadashi Watabe, Richard P Baum
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 28, 2007
Changing role of somatostatin receptor targeted drugs in NET: Nuclear Medicine's viewVikas Prasad, S Fetscher, Richard P Baum
Theranostics|December 8, 2025
Intra-arterial peptide receptor radionuclide therapy (IA-PRRT) in patients with SSTR-expressing neuroendocrine neoplasms: short- and long-term safety and efficacy for up to 13 yearsJingjing Zhang, Birger Mensel, Richard P Baum
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
Purification and labeling strategies for (68)Ga from (68)Ge/ (68)Ga generator eluateDirk Mueller, Ingo Klette, Richard P Baum
Frontiers of Radiation Therapy and Oncology|December 4, 2009
FDG-PET/CT in lung cancer: an updateRichard P Baum, Cyprian Świętaszczyk, Vikas Prasad
Pageof 20